Stocks surged around the world and bonds tumbled after a large-scale coronavirus vaccine study delivered the most-promising results in the battle against the worst pandemic in a century.
More than 85% of S&P 500 companies climbed Monday as the gauge jumped to a record on news that the COVID-19 shot being developed by Pfizer Inc. and BioNTech prevented more than 90% of infections. The enthusiasm also drove the Dow Jones Industrial Average to an all-time high and sparked a rally in small caps.
At 11:10 a.m. New York Time, the S&P 500 was up 2.57% at 3,599.53. The Dow Jones Industrial Average was up 3.76%, or 1,065.95 points, at 29,389.35.
Shares that have been hit hard by the economic toll of lockdowns such as travel stocks and movie theaters jumped, with Carnival Corp. and Cinemark Holdings Inc. surging more than 35%. Stay-at-home companies Zoom Video Communications Inc. and Peloton Interactive Inc. plunged at least 16% on hopes that a return to normal is on the horizon. Online giant Amazon.com Inc. retreated.
A credit derivatives index that measures the perceived risk of high yield dropped by the most in seven months, with junk-rated companies hitting the market in droves to take advantage of a plunge in borrowing costs. Oil soared, while gold, the Japanese yen and the Swiss franc slumped.
Investors pulled out of haven assets and poured cash into markets that are closely tied to economic growth, with a gauge of global stocks also hitting a record high. President-elect Joe Biden Monday announced a new coronavirus task force as his transition team seeks to fulfill a campaign promise to develop a dramatically different approach than President Donald Trump’s to contain the pandemic.
Anthony Fauci, the top infectious disease expert in the U.S., said the vaccine being developed by Pfizer will have a “major impact” on everything we do with regards to the coronavirus going forward.
“The bull market has a ton of ammunition to keep going,” said Chris Larkin, managing director of trading and investing product at ETrade Financial. “With more certainty around the election, a strong quarter of earnings across many sectors, and extremely positive news on the vaccine front, there is little to hold us back.”
Elsewhere, the Australian dollar-yen cross -- a commonly watched risk barometer -- surged by most since June. The Turkish lira soared after the weekend resignation of the country’s economy czar and the dismissal of the central bank chief.
From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.
Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.
“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.
Sellers shift focus: It's not about succession anymore.
Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.
RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.
As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.
